Back to Search

JAESUNG KIM, M.D.

M.D.

Neurology Physician

NPI: 1962834796IndividualAccepts Medicare

Specialties, Licenses & Credentials

Neurology PhysicianPrimary

Psychiatry & Neurology — Neurology

Code: 2084N0400X

33238(OK)MD61054444(WA)MD226000(OR)

CMS Specialties

PrimaryNEUROLOGY

Education

OTHER

Class of 2009

Clinical Trials (1)

1
Linked Trials
0
Recruiting
0
With Results

Risankizumab Long-term Remission Study

NCT04630652ACTIVE_NOT_RECRUITINGPHASE4PRINCIPAL_INVESTIGATOR

Research & Publications (20)

Psoriasis harbors multiple pathogenic type 17 T-cell subsets: Selective modulation by risankizumab.
PMID 39978685·J Allergy Clin Immunol·2025
8-other
Proportion of CD4CD49bLAG-3Type 1 Regulatory T Cells in the Blood of Psoriasis Patients Inversely Correlates with Psoriasis Area and Severity Index.
PMID 29890167·J Invest Dermatol·2018
8-other
Reduction of Inflammatory and Cardiovascular Proteins in the Blood of Patients with Psoriasis: Differential Responses between Tofacitinib and Etanercept after 4 Weeks of Treatment.
PMID 28927890·J Invest Dermatol·2018
3-trial
Efficacy and safety of risankizumab in moderate-to-severe plaque psoriasis (UltIMMa-1 and UltIMMa-2): results from two double-blind, randomised, placebo-controlled and ustekinumab-controlled phase 3 trials.
PMID 30097359·Lancet·2018
3-trial
Risankizumab versus Ustekinumab for Moderate-to-Severe Plaque Psoriasis.
PMID 28423301·N Engl J Med·2017
3-trial
Highly Effective New Treatments for Psoriasis Target the IL-23/Type 17 T Cell Autoimmune Axis.
PMID 27686018·Annu Rev Med·2017
6-review
The Spectrum of Mild to Severe Psoriasis Vulgaris Is Defined by a Common Activation of IL-17 Pathway Genes, but with Key Differences in Immune Regulatory Genes.
PMID 27185339·J Invest Dermatol·2016
4-observational
Molecular Phenotyping Small (Asian) versus Large (Western) Plaque Psoriasis Shows Common Activation of IL-17 Pathway Genes but Different Regulatory Gene Sets.
PMID 26763436·J Invest Dermatol·2016
4-observational
Patients With Psoriasis and Personalized Trade-offs in Treatment Decisions-Lessons Learned From Focus Groups.
PMID 27028481·JAMA Dermatol·2016
8-other
Anti-IL-23A mAb BI 655066 for treatment of moderate-to-severe psoriasis: Safety, efficacy, pharmacokinetics, and biomarker results of a single-rising-dose, randomized, double-blind, placebo-controlled trial.
PMID 25769911·J Allergy Clin Immunol·2015
2-rct
Increased expression of interleukin 23 p19 and p40 in lesional skin of patients with psoriasis vulgaris.
PMID 14707118·J Exp Med·2004
4-observational
A new Leptographium species associated with Tomicus piniperda infesting pine logs in Korea.
PMID 15912944·Mycol Res·2005
7-preclinical
Stereoselective pharmacokinetics of fluoxetine and norfluoxetine enantiomers in pregnant sheep.
PMID 14744943·Drug Metab Dispos·2004
7-preclinical
Leptographium bistatum sp. nov., a new species with a Sporothrix synanamorph from Pinus radiata in Korea.
PMID 15323253·Mycol Res·2004
8-other
Simultaneous determination of sildenafil and its active metabolite UK-103,320 in human plasma using liquid chromatography-tandem mass spectrometry.
PMID 12763541·J Pharm Biomed Anal·2003
8-other
Distinguishing Ophiostoma ips and Ophiostoma montium, two bark beetle-associated sapstain fungi.
PMID 12770706·FEMS Microbiol Lett·2003
7-preclinical
Effects of acute moderate hypoxemia on kinetics of metoclopramide and its metabolites in chronically instrumented sheep.
PMID 12433210·Arch Pharm Res·2002
4-observational
Metabolism of a new neuroprotective agent for ischemia-reperfusion damage, KR-31543 in the rat using liquid chromatography/electrospray mass spectrometry.
PMID 12433202·Arch Pharm Res·2002
7-preclinical
Cholesterol and serotonin transporter polymorphism interactions in late-life depression.
PMID 19329228·Neurobiol Aging·2011
8-other
Brief report: Predictors of heavy Internet use and associations with health-promoting and health risk behaviors among Hong Kong university students.
PMID 19427030·J Adolesc·2010
8-other

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Via practice · 5 locations total

Address
2451 FILLINGIM ST
MOBILE, AL 36617

Locations (5)

Practice Location

2451 FILLINGIM ST, MOBILE, AL
(251) 471-7207

Practice Location

2801 N GANTENBEIN AVE, PORTLAND, OR
(503) 413-2200

Practice Location

1120 S UTICA AVE, TULSA, OK
(918) 579-1000

Practice Location

2211 NE 139TH ST, VANCOUVER, WA
(360) 487-1000

Practice Location

505 NE 87TH AVE STE 460, VANCOUVER, WA
(360) 514-7771

Quick Facts

NPI
1962834796
Entity Type
Individual
Gender
Male
Medicare
Accepted
Specialties
3
Locations
5
Years in Practice
17
Clinical Trials
1
Publications
20

Are you this provider?

Claim Your Profile